The risk of hypoglycemia with tirzepatide remains low, consistent with other GLP-1 receptor agonists, particularly in the absence of concomitant Insulin or sulfonylureas (Frias et al
Misuse may violate federal or provincial laws
You will also need to focus on lifestyle changes, like physical activity and healthy eating
Track Your Cycle If your period changes after starting a GLP-1, use a tracking app or calendar
Borensztein is a triple board-certified endocrinologist and obesity specialist with same-week appointments available in Collingswood, NJ Have questions about getting started, managing side effects, or figuring out which medication is right for you
Your blood pressure goes back up." The two clinical trials were funded by Eli Lilly and Co., the developer of retatrutide